Bab's Hobbs Pharma Guide

Tag: FDA

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025
Justine Traver

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025

iPLEDGE is the FDA's strict program to prevent birth defects from isotretinoin. Learn the 2025 requirements, recent changes, and how to navigate the system safely.

31 Dec 2025

Browse by category

  • Health & Wellness (231)

Latest news

  • Regulatory Exclusivity: How Non-Patent Protections Control Drug Market Access
  • Ocular Migraines: Visual Aura and When to Worry
  • Generic Drug Recalls and Safety Alerts: What Triggers Action
  • Charcoal-Grilled Meats and Medications: What You Need to Know About CYP1A2 Induction
  • Telemedicine Prescriptions and Generics: Digital Health Essentials for 2026

Posts Tags

  • drug interactions
  • online pharmacy
  • side effects
  • bioequivalence
  • medication safety
  • online pharmacy safety
  • medication reconciliation
  • generic drugs
  • patient safety
  • medication side effects
  • Hatch-Waxman Act
  • medication errors
  • generic medications
  • expired medications
  • medication adherence
  • generic medication
  • patent expiration
  • authorized generics
  • narrow therapeutic index
  • generic drug safety
Bab's Hobbs Pharma Guide
Menu
  • About
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact

© 2026. All rights reserved.